Aimei Health Technology Co., Ltd (NASDAQ:AFJK - Get Free Report) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,900 shares, a growth of 35.7% from the December 15th total of 1,400 shares. Currently, 0.0% of the company's shares are sold short. Based on an average daily volume of 54,000 shares, the days-to-cover ratio is currently 0.0 days.
Aimei Health Technology Trading Up 0.4 %
NASDAQ AFJK traded up $0.04 on Thursday, reaching $10.80. 310 shares of the stock traded hands, compared to its average volume of 83,830. Aimei Health Technology has a 12 month low of $10.15 and a 12 month high of $10.85. The company has a fifty day moving average price of $10.64 and a 200-day moving average price of $10.52.
Institutional Trading of Aimei Health Technology
Institutional investors and hedge funds have recently made changes to their positions in the company. Clear Street LLC bought a new position in Aimei Health Technology during the 2nd quarter worth about $575,000. Glazer Capital LLC lifted its holdings in Aimei Health Technology by 7.2% during the second quarter. Glazer Capital LLC now owns 588,774 shares of the company's stock worth $6,094,000 after buying an additional 39,714 shares during the period. Shaolin Capital Management LLC boosted its position in Aimei Health Technology by 33.3% during the 2nd quarter. Shaolin Capital Management LLC now owns 400,000 shares of the company's stock valued at $4,140,000 after acquiring an additional 100,000 shares in the last quarter. Wolverine Asset Management LLC raised its position in shares of Aimei Health Technology by 8.6% in the 3rd quarter. Wolverine Asset Management LLC now owns 539,039 shares of the company's stock worth $5,649,000 after acquiring an additional 42,843 shares in the last quarter. Finally, Mizuho Securities USA LLC raised its position in shares of Aimei Health Technology by 60.7% in the 3rd quarter. Mizuho Securities USA LLC now owns 442,778 shares of the company's stock worth $4,627,000 after acquiring an additional 167,223 shares in the last quarter. 45.58% of the stock is currently owned by institutional investors.
Aimei Health Technology Company Profile
(
Get Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Recommended Stories
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
